Continuous Glucose Monitoring System for Diabetes Management Market

Continuous Glucose Monitoring System for Diabetes Management Market contains market size and forecasts of Continuous Glucose Monitoring (CGM) System for Diabetes Management in global, including the following market information:
Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Continuous Glucose Monitoring (CGM) System for Diabetes Management companies in 2021 (%)
The global Continuous Glucose Monitoring (CGM) System for Diabetes Management market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Wearable Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Continuous Glucose Monitoring (CGM) System for Diabetes Management include Abbott Diabetes Care Inc., Dexcom, Medtronic, Senseonics Holdings, GlySens Incorporated, Meiqi Medical Equipment and San Meditech, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Continuous Glucose Monitoring (CGM) System for Diabetes Management manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Segment Percentages, by Type, 2021 (%)
Wearable
Implantable
Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Segment Percentages, by Application, 2021 (%)
Hospitals & Clinics
Homecare Settings
Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Continuous Glucose Monitoring (CGM) System for Diabetes Management revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Continuous Glucose Monitoring (CGM) System for Diabetes Management revenues share in global market, 2021 (%)
Key companies Continuous Glucose Monitoring (CGM) System for Diabetes Management sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Continuous Glucose Monitoring (CGM) System for Diabetes Management sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Diabetes Care Inc.
Dexcom
Medtronic
Senseonics Holdings
GlySens Incorporated
Meiqi Medical Equipment
San Meditech